Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Turconi

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|April 1, 1991
Synthesis and biological evaluation of new muscarinic receptor antagonists bearing cyclic amidines as cationic headsM Nicola, G B Schiavi, R Micheletti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1991
Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brainA Dumuis, M Sebben, E Monferini, et al.
Journal of Medicinal Chemistry|August 1, 1990
Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonistsM Turconi, M Nicola, M G Quintero, et al.
European Journal of Pharmacology|March 23, 1993
The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigsJ C Van Meel, W Diederen, R Haigh, et al.
European Journal of Pharmacology|October 15, 1991
Pharmacological properties of a novel class of 5-HT3 receptor antagonistsM Turconi, A Donetti, A Schiavone, et al.
Journal of Medicinal Chemistry|May 1, 1990
Synthesis and biological activity of some derivatives of rifamycin PB Cavalleri, M Turconi, G Tamborini, et al.
Optics Express|April 1, 2009
Long spatio-temporally stationary filaments in air using short pulse UV laser Bessel beamsD Abdollahpour, P Panagiotopoulos, M Turconi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1992
Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285A Dumuis, H Gozlan, M Sebben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiationA Sagrada, M Turconi, P Bonali, et al.
Physical Review Letters|December 24, 2019
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of LightF Acernese, M Agathos, L Aiello, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Farmaco (Societa Chimica Italiana : 1989)|April 1, 1991
Synthesis and biological evaluation of new muscarinic receptor antagonists bearing cyclic amidines as cationic headsM Nicola, G B Schiavi, R Micheletti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1991
Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brainA Dumuis, M Sebben, E Monferini, et al.
Journal of Medicinal Chemistry|August 1, 1990
Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonistsM Turconi, M Nicola, M G Quintero, et al.
European Journal of Pharmacology|March 23, 1993
The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigsJ C Van Meel, W Diederen, R Haigh, et al.
European Journal of Pharmacology|October 15, 1991
Pharmacological properties of a novel class of 5-HT3 receptor antagonistsM Turconi, A Donetti, A Schiavone, et al.
Journal of Medicinal Chemistry|May 1, 1990
Synthesis and biological activity of some derivatives of rifamycin PB Cavalleri, M Turconi, G Tamborini, et al.
Optics Express|April 1, 2009
Long spatio-temporally stationary filaments in air using short pulse UV laser Bessel beamsD Abdollahpour, P Panagiotopoulos, M Turconi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1992
Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285A Dumuis, H Gozlan, M Sebben, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiationA Sagrada, M Turconi, P Bonali, et al.
Physical Review Letters|December 24, 2019
Increasing the Astrophysical Reach of the Advanced Virgo Detector via the Application of Squeezed Vacuum States of LightF Acernese, M Agathos, L Aiello, et al.
Pageof 4